Skip to main content
. 2015 Aug 20;9:153–163. doi: 10.1016/j.nicl.2015.08.001

Table 2.

Medication profile, clinical symptoms, BIS–BAS and UPSA functional outcome scores (mean, SD) in schizophrenia (SZ) participants.

SZ (N = 37)
 1st generation (N) 8
 2nd generation (N) 32
 Multiple (N) 8
 No antipsychotic (N) 0
Other psychiatric medication
 Antidepressants or mood stabilizers (N) 23
 Benzodiazepines (N) 9
Mean chlorpromazine (CPZ) equivalents 374.96 (SD = 555.62)
Mean cogentin equivalents 1.07 (SD = 1.51)
 Overall clinical symptom severity (PANSS) 2.14 (SD = 0.55)
 Positive symptom severity (PANSS) 2.55 (SD = 1.03)
 Negative symptom severity (PANSS) 2.06 (SD = 0.89)
 BAS-Drive 2.65 (SD = .75)
 BAS-Fun seeking 2.78 (SD = .56)
 BAS-Reward responsiveness 3.56 (SD = .36)
 BIS 3.05 (SD = .61)
 UPSA 73.01 (SD = 12.58)